Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3862007 Title: COMPOSITIONS PHARMACEUTIQUES CONTENANT DU NITRITE DE SODIUM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
211610118
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
3862007
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
11/02/2010
Grant date:
25/03/2026
EP publication date:
11/08/2021
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
25/03/2026
EP B1 publication date:
25/03/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
11/02/2030

Applicant

Name:
Hope Medical Enterprises, Inc. d.b.a. Hope Pharmaceuticals
Legal Form:
From:
25/03/2026
Address:
16416 N. 92nd Street 125, Scottsdale, AZ 85260, United States (US)
To:

Inventor

1

Name:
SHERMAN, Craig
Legal Form:
Address:
Scottsdale, Arizona 85260, United States (US)

2

Name:
LEPINE, Anthony James
Legal Form:
Address:
Greendale, Wisconsin 53129, United States (US)

3

Name:
SMITH, Catherine, Marie
Legal Form:
Address:
Grafton, Wisconsin 53024, United States (US)

4

Name:
WIRTZ, Kevin, Robert
Legal Form:
Address:
Eden Prairie, Wisconsin 55346, United States (US)

5

Name:
SCHULZE, Erich
Legal Form:
Address:
Lake Elsinore, California 92530, United States (US)

Priority

1

Priority patent number:
224021 P
Priority date:
08/07/2009
Priority country:
United States (US)

2

Priority patent number:
151820 P
Priority date:
11/02/2009
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 33/00; C01B 21/50; A61K 31/17; A61K 31/4418; A61K 31/4709; A61K 31/519; A61P 9/00; A61P 11/00; A61P 17/00; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/03/2027
Annual fee number:
18
Annual fee amount:
500 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type